TY - JOUR T1 - <sup>18</sup>F DCFPyL PET Acquisition, Interpretation and Reporting: Suggestions Post Food and Drug Administration Approval JF - Journal of Nuclear Medicine JO - J Nucl Med DO - 10.2967/jnumed.121.262989 SP - jnumed.121.262989 AU - Hong Song AU - Andrei Iagaru AU - Steven P. Rowe Y1 - 2021/09/01 UR - http://jnm.snmjournals.org/content/early/2021/09/15/jnumed.121.262989.abstract N2 - 18F-DCFPyL was recently approved by the FDA for evaluation prior to definitive therapy and for biochemical recurrence. Here we focus on the key data that justify the clinical use of 18F-DCFPyL, as well as those aspects of protocol implementation and image interpretation that are important to the nuclear medicine physicians and radiologists who will interpret 18F-DCFPyL PET/CT and PET/MR scans. ER -